FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/12/007529 [Registered on: 02/12/2016] Trial Registered Retrospectively
Last Modified On: 11/12/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Randomozed,Blinded, placebo controlled, clinical study to evaluate the efficacy of Dabur Babool Neem Toothpaste DRDC/PC/8003 in oral hygeine and dental care 
Scientific Title of Study   A Double blind, randomized, placebo controlled, clinical study to evaluate the efficacy of a Dabur Babool Neem Toothpaste DRDC/PC/8003 in oral hygeine and dental care 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rahul Bhowate 
Designation  Professor 
Affiliation  Department of Oral medine & Radiology, Sharad Pawar Dental College & Hospital, Wardha 
Address  Department of Oral medine & Radiology, Sharad Pawar Dental College & Hospital, Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  07152245968  
Fax    
Email  dr_bhowate@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Arun Gupta 
Designation  Head-Medical Affairs & Clinical Resaerch 
Affiliation  Dabur India ltd. 
Address  Dabur Research & Development Center, Dabur India Ltd., Sahibabd, Ghaziabad (U.P)

Ghaziabad
UTTAR PRADESH
201010
India 
Phone  012033878614  
Fax    
Email  arun.gupta@dabur.com  
 
Details of Contact Person
Public Query
 
Name  Sunil Kumar 
Designation  Research Scientist 
Affiliation  Dabur India ltd. 
Address  Dabur Research & Development Center, Dabur India Ltd., Sahibabd, Ghaziabad (U.P)

Ghaziabad
UTTAR PRADESH
201010
India 
Phone  0120338562  
Fax    
Email  sunil.kumar@dabur.com  
 
Source of Monetary or Material Support  
Dabur India Ltd 
 
Primary Sponsor  
Name  Dabur India Ltd 
Address  Dabur Research & Development Center, dabiu India Ltd., Sahibabd, Ghaziabad (U.P 
Type of Sponsor  Pharmaceutical industry-Global 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rahul Bhowate  Department of Oral Medicine & Radiology, Sharad Pawar Dental College & Hospital  DEPARTMENT OF ORAL MEDICINE & RADIOLOGY SHARAD PAWAR DENTAL COLLEGE SAWANGI (MEGHE) WARDHA (MAHARASHTRA) PIN - 442004
Wardha
MAHARASHTRA 
07152245968

dr_bhowate@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Instittutional Ethics Committee, Datta Meghe Institute of Medical Sciences University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K051||Chronic gingivitis, (2) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dabur Babool Neem Toothpaste (DRDC/PC/8003)  Subject were advised to brush with Babool Neem Toothpaste two times a day for 12 week 
Comparator Agent  Placebo  Subjects were advised to brush two times a day for 6 weeks 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  Periodontitis & Gingival Group:
1. Subjects of both sexes in the age groups of 18-45 yrs
2. Subjects willing to sign informed consent form
3. Subjects who have at least 20 natural uncrowned teeth excluding third molars.
4. Subjects with periodontitis and gingivitis
5. Subjects with ability to comply with all study requirements.
6. Subjects having gingivitis with gingival index > 1 at more than 60 % of sites examined.
7. Subjects with tooth stains.
8. Subjects having dental plaque with plaque index of 2 or more.

Healthy Group:
1. Healthy subjects of both sexes in the age group of 18 to 45 years.
2. Subjects willing to sign informed consent form.
3. Subjects who have at least 20 natural uncrowned teeth excluding third molars.
4. Subjects with ability to comply with all study requirements.


 
 
ExclusionCriteria 
Details  Periodontitis & Gingival Group:
1. Subjects having pain and multiplicity of periodontal/gingival problems or advanced generalized chronic inflammatory periodontal disease or any gross oral pathology.
2. Subjects having history of known sensitivity or oral mucosal tissue reaction to toothpaste.
3. Subjects having any serious systemic disease.
4. Subjects with any external dental treatment like scaling, polishing, flossing etc.
5. Subjects with Upper respiratory tract infection, Urinary tract infection, Gastrointestinal Tract infection, Skin infection.
6. Subjects with history of intake of antibiotics and anti-inflammatory drugs for the past 3-4 weeks
7. Subjects with history of fluoride treatment for the past two weeks.
8. Pregnant or lactating mothers.
9. Subjects with involvement in any concurrent study the nature of which may affect the parameters being investigated in the study.
10. Subjects not willing to sign informed consent.
11. Subjects not willing to come for follow-up when required
12. Subjects with presence of relatively severe tetracycline stained teeth.

Healthy Group:
As per the exclusion criteria for gingivitis & periodontitis group.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
For GIngivitis & Periodontitis Group:
change in scores of gingivitis &/or signs & symptoms, change in microbiologiacl assesment (swab culture), elimination/reduction in malodor if applicable, change in scores of lobene stain &/or signs & symptoms, change in plaque scores &/or signs & symptoms, change in clinivcal attachement loss
For Healthy Group:
Reduction in microbial counts (swab culture)  
12 weeks for gingivits & periodontitis group & 6 weeks for healthy group 
 
Secondary Outcome  
Outcome  TimePoints 
For GIngivitis & Periodontitis Group:
Global patient & Investigator evaluation, ADR/AE profile
For Healthy Group:
Lobene index, organoleptic index, plaque assesment/plaque index, gingival index, clinical attachment loss, ADR/AE profile 
12 weeks for gingivits & periodontitis group & 6 weeks for healthy group
 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   N/A 
Date of First Enrollment (India)   24/09/2010 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Result s of the study of this clinical Trial may be used for publishing scientific papers. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This is a single centerd, Double Blind; Placebo Controlled; randomized,  clinical study to evaluate the  efficacy of a  Dabur Babool Neem Toothpaste  in oral Hygiene and Dental Care. 50 subjects were enrolled in the study on the basis of two groups one group is diseased group having Gingivitis and Periodontitis and 20 Healthy Volunteers were enrolled in other group.  For Gingivitis and Periodontitis group Duration of the study was 12 weeks of use of product and one week follow up where as in Healthy group duration of study was 6 weeks of use of product.Subjects were assessed on various parameters like: Change in pH of saliva,change in pH of gingival crevicular fluid,change in gingival crevicular flow,reduction in microbial counts (swab culture)change in malodor,change in stain score,change in gingival index,change in plaque scores,change in clinical attachment loss scores,global patient evaluation,global physical evaluation,Adverse Reactions/Adverse Events. 
Close